Celsion Corp (NASDAQ:CLSN)

CAPS Rating: 1 out of 5

A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.

Recs

0
Player Avatar dunce12 (< 20) Submitted: 1/13/2013 6:01:41 PM : Outperform Start Price: $8.61 CLSN Score: -98.70

will be in the low teens in two or three weeks then on to the mid 20's by April, 30's by end of 2013 and 40's sometime 2014

Member Avatar trackjakeambrose (59.42) Submitted: 1/31/2013 2:40:00 PM
Recs: 0

a huge mistake in investing is to try to make glorious predictions of price gain.......

Featured Broker Partners


Advertisement